| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCR
|
breakpoint cluster region
|
|
CALR
|
calreticulin
|
|
CCND1
|
cyclin D1
|
|
CD177
|
CD177 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CHEK2
|
checkpoint kinase 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
GH1
|
growth hormone 1
|
|
HDAC11
|
histone deacetylase 11
|
|
HDAC9
|
histone deacetylase 9
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGH
|
immunoglobulin heavy locus
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
LCN2
|
lipocalin 2
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDHC
|
lactate dehydrogenase C
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
PML
|
promyelocytic leukemia
|
|
PTX3
|
pentraxin 3, long
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
VEGFA
|
vascular endothelial growth factor A
|
